Lipopolysaccharide induces nitric oxide synthase expression and platelet-activating factor increases nitric oxide production in human fetal membranes in culture

Reproductive Biology and Endocrinology

Volumn 2, Issue , 2004, Pages

  Seyffarth, Gunter ^a   Nelson, Paul N ^a   Dunmore, Simon J ^a   Rodrigo, Nalinda ^b   Murphy, Damian J ^b   Carson, Ray J ^c  

^a UNIVERSITY OF WOLVERHAMPTON   (United Kingdom)

^b NEW CROSS HOSPITAL   (United Kingdom)

^c Institute for Clean Growth and Future Mobility   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; AUTACOID; BACTERIUM LIPOPOLYSACCHARIDE; INDUCIBLE NITRIC OXIDE SYNTHASE; MESSENGER RNA; NITRIC OXIDE; NITRITE; RNA; THROMBOCYTE ACTIVATING FACTOR; LIPOPOLYSACCHARIDE; NITRIC OXIDE SYNTHASE; NOS2 PROTEIN, HUMAN;

ARTICLE; BIOSYNTHESIS; CESAREAN SECTION; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CULTURE MEDIUM; ENZYME INDUCTION; EXPLANT; FEMALE; FETUS; FETUS MEMBRANE; GESTATIONAL AGE; HUMAN; HUMAN TISSUE; INTRAUTERINE INFECTION; LABOR; MEASUREMENT; PREMATURE LABOR; PROTEIN EXPRESSION; QUALITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; TISSUE CULTURE; CHEMISTRY; CULTURE TECHNIQUE; DRUG EFFECT; EMBRYO MEMBRANE; ENZYMOLOGY; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; METHODOLOGY;

CULTURE TECHNIQUES; ENZYME INDUCTION; EXTRAEMBRYONIC MEMBRANES; HUMANS; IMMUNOHISTOCHEMISTRY; LIPOPOLYSACCHARIDES; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; PLATELET ACTIVATING FACTOR;

EID: 4344605625     PISSN: 14777827     EISSN: None     Source Type: Journal    
DOI: 10.1186/1477-7827-2-29     Document Type: Article

References (47)

1. Keirse MJ: New perspectives for the effective treatment of preterm labor. Am J Obstet Gynecol 1995, 173:618-628.
2. McGregor JA, French JI, Lawellin D, Todd JK: Preterm birth and infection: pathogenic possibilities. Am J Reprod Immunol Microbiol 1988, 16:123-132.
3. Romero R, Mazor M: Infection and preterm labor. Clin Obstet Gynecol 1988, 31:553-584.
4. Toth M, Witkins SS, Ledger W, Thaler H: The role of infection in the etiology of preterm birth. Obstet Gynecol 1988, 71:723-726.
5. Rajasingam D, Bennett PR, Alvi SA, Elder MG, Sullivan MH: Stimulation of prostaglandin production from intact human fetal membranes by bacteria and bacterial products. Placenta 1998, 19:301-306.
6. Fortunato SJ, Lombardi SJ, Menon R: Immunoreactivity of human fetal membranes to peptidoglycan polysaccharide (PGPS): cytokine response. J Perinat Med 1998, 26:442-447.
7. Silver RK, Caplan MS, Kelly AM: Amniotic fluid platelet-activating factor (PAF) is elevated in patients with tocolytic failure and preterm delivery. Prostaglandins 1992, 43:181-187.
8. Kelly RW: Inflammatory mediators and parturition. Rev Reprod 1996, 1:89-96.
9. Dudley DJ: Immunoendocrinology of preterm labor: the link between corticotropin-releasing hormone and inflammation. Am J Obstet Gynecol 1999, 180:S251-256.
10. Romero R, Gomez R, Ghezzi F, Yoon BH, Mazor M, Edwin SS, Berry SM: A fetal systemic inflammatory response is followed by the spontaneous onset of preterm parturition. Am J Obstet Gynecol 1998, 179:186-193.
11. Frenkel RA, Mugurama K, Johnston JM: The biochemical role of platelet-activating factor in reproduction. Prog Lipid Res 1996, 35:155-168.
12. Toyoshima K, Narahara H, Furukaua M, Frenkel RA, Johnston JM: Platelet-activating factor. Role in fetal lung development and relationship to normal and premature labour. Clin Perinatol 1995, 22:263-280.
13. Hoffamn DR, Truong CT, Johnston JM: The role of platelet-activating factor in human fetal lung maturation. Am J Obstet Gynecol 1986, 155:70-75.
14. Billah MM, Johnston JM: Identification of phospholipid platelet-activating factor (1-0-alkyl-2-acetyl-sn-glycero-3-phosphocholine) in human amniotic fluid and urine. Biochem Biophys Res Commun 1983, 113:51-58.
15. Nishihira J, Ishibashi T, Imai Y, Muramatsu T: Mass spectrometric evidence for the presence of platelet-activating factor (1-0-alkyl-2-acetyl-sn glycero-3-phosphocholine) in human amniotic fluid during labour. Lipids 1984, 19:907-910.
16. Hoffman DR, Romero R, Johnston JM: Detection of platelet-activating factor in amniotic fluid of complicated pregnancies. Am J Obstet Gynecol 1990, 162:525-528.
17. Lopez Bernal A, Newman GE, Phizackerley PJ, Laird E, Ross C, Barlow DH: Platelet-activating factor levels in human amniotic follicular and amniotic fluids. Eur J Obstet Gynecol Reprod Biol 1992, 46:39-44.
18. McManus LM: Pathobiology of platelet-activating factors. Pathol Immunopathol Res 1986, 5:104-117.
19. Morris C, Khan H, Sullivan MH, Elder MG: Effects of platelet-activating factor on prostaglandin E2 production by intact fetal membranes. Am J Obstet Gynecol 1992, 166:1228-1231.
20. Qu XW, Rozenfeld RA, Huang W, Sun X, Tan XD, Hsueh W: Rolesof nitric oxide synthases in platelet-activating factor-induced intestinal necrosis in rats. Crit Care Med 1999, 27:356-364.
21. Ahmed A, Dearn S, Shams M, Li XF, Sangha RK, Rola-Pleszczynski M, Jiang J: Localization, quantification, and activation of platelet-activating factor receptor in human endometrium during the menstrual cycle: PAF stimulates NO, VEGF, and FAKpp125. FASEB J 1998, 12:831-843.
22. Dearn S, Rahman M, Lewis A, Ahmed Z, Eggo MC, Ahmed A: Activation of platelet-activating factor (PAF) receptor stimulates nitric oxide (NO) release via protein kinase C-alpha in HEC-1B human endometrial epithelial cell line. Mol Med 2000, 6:37-49.
23. Maul H, Shi L, Marx SG, Garfield RE, Saade GR: Local application of platelet-activating factor induces cervical ripening accompanied by infiltration of polymorphonuclear leukocytes in rats. Am J Obstet Gynecol 2002, 187:829-833.
24. Thomson AJ, Lunan CB, Cameron AD, Cameron IT, Greer IA, Norman JE: Nitric oxide donors induce ripening of the human uterine cervix: a randomised controlled trial. Br J Obstet Gynaecol 1997, 104:1054-1057.
25. Wieser F, Gruber DM, Tschugguel W, Huber JC: Progesteron und die Stickstoffmonoxid-systeme. Zentralbl Gynakol 1997, 119(Suppl 2):12-16.
26. Ghabour MS, Eis AL, Brockman DE, Pollock JS, Myatt L: Immunohistochemical characterization of the placental nitric oxide synthase expression in pre-eclampsia. Am J Obstet Gynecol 1995, 173:687-694.
27. Beck KF, Sterzel RB: Cloning and sequencing of the proximal promoter of the rat iNOS gene: activation of NFkB is not sufficient for transcription of the iNOS gene in rat mesanglial cells. FEBS Lett 1996, 394:263-267.
28. Laubach VE, Garvey EP, Sherman PA: High-level expression of human inducible nitric oxide synthase in Chinese hamster ovary cells and characterization of the purified enzyme. Biochem Biophys Res Commun 1996, 218:802-807.
29. Dennes WJ, Slater DM, Bennett PR: Nitric oxide synthase mRNA expression in human fetal membranes: a possible role in parturition. Biochem Biophys Res Commun 1997, 233:276-278.
30. Eis AL, Brockman DE, Myatt L: Immunolocalization of the inducible nitric oxide synthase isoform in human fetal membranes. Am J Reprod Immunol 1997, 38:289-294.
31. Marinoni E, Di Iorio R, Villaccio B, Alberini A, Rota F, Cosmi EV: Amniotic fluid nitric oxide metabolite levels and nitric oxide synthase localization in feto-placental tissues are modified in association with human labor. Eur J Obstet Gynecol Reprod Biol 2000, 89:47-54.
32. Kakui K, Sagawa N, Itoh H, Yura S, Korita D, Takemura M, Nuamah MA, Fujii S: Expression of nitric oxide synthase isoforms in the human placenta is not altered by labor. Endocr J 2003, 50:535-544.
33. Ledingham MA, Thomson AJ, Young A, Macara LM, Greer IA, Norman JE: Changes in the expression of nitric oxide synthase in the human uterine cervix during pregnancy and parturition. Mol Hum Reprod 2000, 6:1041-1048.
34. O'Banion MK, Fadowski HB, Winn V, Young DA: A serum- and glucocorticoid-regulated 4 kb mRNA encodes a COX-2 related protein. J Biol Chem 1992, 266:23261-23267.
35. Yallampalli C, Byam-Smith M, Nelson SO, Garfield RE: Steroid hormones modulate the production of nitric oxide and cGMP in the rat uterus. Endocrinology 1994, 134:1971-1974.
36. Brown NL, Alvi SA, Elder MG, Bennett PR, Sullivan MH: Interleukin-beta and bacterial endotoxin change the metabolism of prostaglandins E2 and F2 alpha in intact term fetal membranes. Placenta 1998, 19:625-630.
37. Brown NL, Alvi SA, Elder MG, Bennett PR, Sullivan MH: A spontaneous induction of fetal membrane prostaglandin production precedesclinical labour. J Endocrinol 1998, 157:R1-R6.
38. Robbins RA, Springall DR, Warren JB, Kwon OJ, Buttery LD, Wilson AJ, Adcock IM, Riveros-Moreno V, Moncada S, Polak J, Barnes PJ: Inducible nitric oxide synthase is increased in murine lung epithelial cells by cytokine stimulation. Biochem Biophys Res Commun 1994, 198:835-843.
39. Laskin DL, Pendino KJ: Macrophages and inflammatory mediators in tissue injury. Ann Rev Pharmacol Toxicol 1995, 35:655-677.
40. Athanassakis I, Aifantis I, Ranella A, Giouremou K, Vassiliadis S: Inhibition of nitric oxide production rescues LPS-induced fetal abortion in mice. Nitric Oxide 1999, 3:216-224.
41. Shukla SD: Platelet-activating factor receptor and signal transduction mechanisms. FASEB J 1992, 6:2296-2301.
42. Kravchenko VV, Pan Z, Han J, Herbert JM, Ulevitch RJ, Ye RD: Platelet-activating factor induces NF kappa B activation through a G protein-coupled pathway. J Biol Chem 1995, 270:14928-14934.
43. De Plaen IG, Tan XD, Chang H, Qu XW, Liu QP, Hsueh W: Intestinal NF-kappa B is activated, mainly as p50 homodimers, by platelet-activating factor. Biochim Biophys Acta 1998, 1392:185-192.
44. Alvi SA, Brown NL, Bennett PR, Elder MG, Sullivan MH: Corticotrophin releasing hormone and platelet-activating factor induce transcription of the type-2 cyclo-oxygenase gene in human fetal membranes. Mol Hum Reprod 1999, 5:476-480.
45. Chaud MA, Franchi AM, Beron de Astrada M, Gimeno MF: Nitric oxide mediates platelet-activating factor stimulatory action on uterine prostaglandin production. Prostaglandins Leukot Essent Fatty Acids 1998, 58:55-59.
46. Maul H, Shi L, Marx SG, Garfield RE, Saade GR: Platelet-activating factor antagonist WEB-2170 inhibits lipopolysaccharide-induced, but not antiprogestin-induced, preterm cervical ripening in timed-pregnant rats. Am J Obstet Gynecol 2003, 189:963-967.
47. Elovitz MA, Wang Z, Chien EK, Rychlik DF, Phillippe M: A new model for inflammation-induced preterm birth: the role of platelet-activating factor and Toll-like receptor-4. Am J Pathol 2003, 163:2103-2111.